Home > > Middle East & Africa And Global Nutrigenomics Testing Market- Size, Share, Growth Rate, and Forecast
The Middle East & Africa Nutrigenomics Testing market was valued at $128.8 Million in 2023, and is projected to reach $291.2 Million by 2030 growing at a CAGR of 12.41% from 2024 to 2030. Obesity segment is expected to be the highest contributor to this market, with $42.2 Million in 2023, and is anticipated to reach $98.9 by 2030, registering a CAGR of 12.98%. Diabetes segment is anticipated to reach $59.5 Million by 2030 with the highest CAGR of 13.01%. Obesity and Cardiovascular Diseases segments collectively expected to account for about 58.7% share of the Middle East & Africa Nutrigenomics Testing market in 2023, with the former constituting around 32.8% share. Diabetes and Obesity segments are expected to witness significant growth rates at a CAGR of 13.01% and 12.98% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 52.4% in the overall Middle East & Africa Nutrigenomics Testing market in 2023, and is anticipated to reach 54.4% by 2030. Application Obesity Diabetes Cancer Cardiovascular Diseases Other Applications Procedure Hospitals & Clinics Online platforms Other Procedures BY REGION North America U.s. Canada Mexico Europe Germany France U.k. Italy Spain Russia Rest of Europe Asia China India Japan Australia South Korea Rest of Asia Middle East & Africa Brazil South Africa GCC Rest of MENA